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Bacteria produce a wide variety of both proteinaceous and
nonproteinaceous molecules for defense, mediation of micro-
bial competitions, and signaling purposes. Of the protein-
based molecules, there are examples of large folded polypep-
tides that are translated conventionally from genes as well as
smaller peptides that are assembled nonribosomally by peptide
synthetases (41). The latter often contain modified amino ac-
ids, including those with altered chirality, N-methylation, and
nonamide backbone bonds. Such modifications may give the
producing organism an advantage, as the modified molecules
are less susceptible to the normal proteolytic cleavage reac-
tions of proteins. Cyclization is another strategy that has been
used, exemplified by well-known natural products such as cy-
closporin A and gramicidin S. The advantages of such a strat-
egy for stabilizing peptides may be seen by the fact that a
significant number of macrocyclic natural products have found
pharmaceutical applications, including, for example, the wide-
spread use of cyclosporin A as an immunosuppressive agent.
Synthetic cyclic peptides are also widely used as lead molecules
in the pharmaceutical industry.
The biosynthesis of cyclic nonribosomal peptides such as
cyclosporin A and polyketides such as the antibiotic erythro-
mycin, as well as hybrid peptide/polyketide drugs such as rapa-
mycin, has recently been reviewed (41). Briefly, it involves the
ordered condensation of monomer building blocks by an en-
zyme-driven process to produce a linear acyl chain that is
cyclized by a thioester domain at the C-terminal end of the
biosynthetic assembly line (41).
Over recent years, several examples of naturally occurring
circular proteins fundamentally different from the nonriboso-
mal cyclic peptides have been discovered (58). These mole-
cules are true proteins in that they have a well-folded three-
dimensional structure and are produced via translation of
genes. Their only difference from conventional proteins is that
their gene-coded precursor proteins are posttranslationally
modified to join the N and C termini to produce a seamless
circle of peptide bonds. Such circular proteins occur in a di-
verse range of organisms, from bacteria to plants and animals,
but the focus here is on circular proteins produced by bacteria.
In this review we describe the sequences and structures of
these proteins and examine what is known about their biosyn-
thesis. We compare them to other recently discovered circular
proteins from higher organisms and speculate on the possible
roles of backbone cyclization.
Circular proteins were unknown a decade ago, and the field
is still in its infancy, but there are now enough examples known
to make it timely to examine the structures and properties of
bacterially produced circular proteins. Bacterial protein ex-
pression has also been used to facilitate the production of
synthetic circular variants of noncyclic proteins, including
-lactamase (31) and green fluorescent protein (30). These
studies have adapted intein-based methods to enable protein
ligations that result in circular proteins. While the focus of this
review is on naturally occurring circular proteins, the studies
on artificially produced circular proteins highlight the impor-
tance and interest in this area. We note at the outset that we
generally use the term circular rather than cyclic to emphasize
the fact that the molecules that we are focusing on have a
head-to-tail cyclized backbone rather than other cross-links,
such as disulfide bonds, that might make just part of the struc-
ture cyclic. While the molecules that we examine are thus
topologically circular, as we shall see, they fold into complex
three-dimensional shapes.
SEQUENCES AND STRUCTURES
The currently known circular proteins from bacteria range in
size from 21 to 78 amino acids. From the sequences summa-
rized in Table 1, it is evident that while they vary widely in size
and primary structure, a common theme among these proteins
is a high proportion of hydrophobic residues. The structural
data available for cyclic proteins from both microorganisms
and higher organisms have been derived almost exclusively
from nuclear magnetic resonance (NMR) analysis. In general,
the structures are well defined and contain elements of regular
secondary structure. Thus, apart from the fact that no termini
are present, the structures are not fundamentally different
from those of conventional linear proteins.
The smallest circular protein of bacterial origin, microcin
J25 (MccJ25), was first isolated from Escherichia coli AY25
(54). Microcins are a group of antimicrobial peptides produced
by members of the family Enterobacteriaceae under conditions
of nutrient depletion that target microbes phylogenetically re-
lated to the producer strain (19). MccJ25 induces filamentation
in an SOS-independent way (54). In attempts to identify the
mode of action, a resistant strain of E. coli carrying a mutation
in the rpoC gene coding for the  subunit of RNA polymerase
was isolated (17). Subsequent experiments in which the wild-
type rpoC gene was introduced into MccJ25-sensitive strains
resulted in complete resistance, identifying RNA polymerase
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as the target of MccJ25 and possibly explaining the observed
filamentation, which may result from impaired transcription of
genes involved in cell division (17). Further mutational analysis
has provided a more detailed understanding of the mode of
interaction of MccJ25 with RNA polymerase (62). Other stud-
ies have shown that MccJ25 has the ability to disrupt the
membrane of Salmonella enterica serovar Newport but not E.
coli, suggesting that the mechanism of action might be different
against different bacterial strains (52). Interestingly, the bioac-
tivity of a thermolysin-linearized form of MccJ25 against E. coli
strains is significantly reduced compared to the native form,
although it retains significant activity against S. enterica serovar
Newport (6). These findings suggest that the circular structure
is probably more crucial for a specific protein-protein interac-
tion than a nonspecific interaction with the bacterial mem-
brane.
MccJ25 has been reported to contain a head-to-tail cyclized
backbone based on enzyme cleavage data, sequencing, mass
spectrometry, and NMR studies (6). It has been structurally
characterized in methanol by NMR and proposed to adopt a
highly compact globular structure, as shown in Fig. 1 (5). The
structure has been described as a distorted antiparallel -sheet
that is twisted and folded back onto itself. Despite the highly
hydrophobic nature of most of the residues in MccJ25, no real
hydrophobic core is present due to its small size. Instead, most
side chains are oriented towards the surface of the structure,
forming hydrophobic patches, as indicated in Fig. 1 (panels b
and c). The protection of the peptide backbone provided by
these side chains may be responsible for the proteolytic stabil-
ity of MccJ25 (5).
It is interesting that a synthetic linear analogue did not fold
correctly and did not have antibacterial activity even though a
thermolysin-linearized derivative of the native peptide re-
tained some structure and activity. Blond et al. suggested that
folding into the native conformation may be assisted by a
helper molecule in vivo (4). It is unusual for a small peptide
lacking disulfide bonds to adopt such a well-defined structure
as has been suggested for the native peptide, and it seems
surprising that the additional constraint of a circular backbone
would alone be sufficient to produce the observed fold. How-
ever, in our view there remain some inconsistencies in the
spectroscopic data presented for MccJ25 and its thermolysin-
linearized derivative that lead to questions about the exact
structure of the peptide. At the time of writing, it remains
unclear whether the peptide is in fact backbone cyclized or
whether there are some other unusual chemical linkages sta-
bilizing the structure. There may well be some revision of the
primary structure as further investigations on this peptide are
carried out.
Microcins produced by gram-negative bacteria have a coun-
terpart in gram-positive bacteria, namely bacteriocins. The
bacteriocins from lactic acid bacteria have been divided into
four major classes based on size and structural features (40, 50,
60). Of interest here is class II, comprising small heat-stable
peptides without lanthionine linkages, and more specifically
subclass IIf, comprising atypical class II bacteriocins (60). At
present this subclass has five members, of which two have been
confirmed to be cyclic and one has been suggested to be cyclic
based on sequence homology (60). These three members are
discussed in further detail.
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Gassericin A (GasA) has been isolated from two different
strains of lactic acid bacteria, Lactobacillus gasseri LA39 (39)
and Lactobacillus reuteri LA6 (57). When first described in
1991, then under the name reutericin 6, the peptide was
thought to be significantly smaller, with an apparent molecular
size of 3 kDa on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). However, subsequent work has
shown that it carries a head-to-tail cyclization, comprises 58
residues, and has a mass of 5,652 Da (36, 38). No structural
data are available, but its behavior on SDS-PAGE suggests a
compact structure that also appears to be very stable, since
heating for 60 min at 100°C does not destroy its inhibitory
activity (57). More than 74% of the residues of GasA are
hydrophobic and most probably exposed on the surface of the
peptide, as evident from the fact that it cannot be eluted from
a C18 column by methanol, acetonitrile, or 2-propanol (34).
The secondary structure has been predicted to be helical, at
least to some extent (38).
In addition to its antimicrobial activity against several Lac-
tobacillus species, GasA is also active against several food-
borne pathogenic bacteria, including Listeria monocytogenes,
Bacillus cereus, and Staphylococcus aureus (36). GasA has been
shown to be 98% identical to acidocin B, another bacteriocin
isolated from Lactobacillus acidophilus M46 (46). While the
chemical properties of acidocin B have not been fully charac-
terized, the facts that this peptide differs from GasA at only a
few positions and has a significantly lower apparent molecular
weight on SDS-PAGE, consistent with what is observed for
GasA, strongly suggest a macrocyclic structure.
Like GasA, bacteriocin AS-48 (AS-48), the second member
of group IIf with a confirmed circular backbone, is also active
against both related and unrelated gram-positive bacteria as
well as several pathogenic organisms, including Staphylococcus,
Enterococcus, and Salmonella species (1, 2, 24). According to
Ga´lvez et al., AS-48 can interact directly with the cytoplasmic
membrane of certain microorganisms without the mediation of
surface receptors (24). AS-48 elicits its effects by inserting itself
into the cytoplasmic membrane and forming pores. This ren-
ders the membranes permeable to ions and small molecules,
leading to the release of cytoplasmic material and ultimately
FIG. 1. Solution structures of the circular bacterial proteins for which three-dimensional structures have been determined. (a) Ribbon
representation of MccJ25 (PDB code 1HG6), with the -strands shown as arrows. (b and c) Surface diagrams of MccJ25, with b in the same
orientation as a and c rotated 180° about the y axis. White, green, and red represent hydrophobic, hydrophilic, and negatively charged residues,
respectively. (d) Ribbon representation of AS-48 (PDB code 1E68), showing the five-helix bundle. (e and f) Surface diagrams of AS-48, with e in
the same orientation as d and f rotated 180° about the y axis. White, green, blue, and red represent hydrophobic, hydrophilic, positively charged,
and negatively charged residues, respectively. Glycine residues are shown in light blue.
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causing the lysis of sensitive cells (25). Because of its broad
spectrum of antimicrobial activity and its temperature and pH
stability, AS-48 has been proposed as a promising candidate
for food biopreservation (1).
The three-dimensional structure of AS-48 as solved by NMR
(26) is shown in Fig. 1. The fold is characterized by a globular
arrangement of five -helices connected by five short turn
regions and enclosing a compact hydrophobic core. A very
similar fold and membranolytic activity were earlier described
for the linear mammalian protein NK-lysin from natural killer
cells, suggesting a similar mechanism of action (26). Both NK-
lysin and AS-48 have exceptional stability and high resistance
to temperature denaturation (3, 9). Both contain a significant
hydrophobic core and, in the case of NK-lysin, the fold is
further stabilized by three disulfide bonds. While AS-48 lacks
disulfide bonds, the additional stability is likely introduced
from the circular backbone.
It is interesting that the backbone cyclization of the AS-48
precursor occurs at a point in the sequence corresponding to
the middle of one of the -helices (5, spanning residues 64 to
5), which suggests that cyclization is absolutely necessary for
the correct folding and function of AS-48 (8). This is supported
by preliminary studies indicating that overexpressed linear
(i.e., noncyclic) AS-48 does not adopt a native fold. In partic-
ular, the interactions of three of the internal hydrophobic res-
idues of 5, Val67, Met1 and Phe5, with the hydrophobic core
are thought to be essential for the stability of the five-helix
globule (26). Figure 2 illustrates the hydrophobic interactions
in the core and highlights the importance of these residues for
the overall stability of AS-48. One would expect that in a
linearized version of AS-48, the crucial helix, 5, would be
unfolded and the important interactions with the core would
be lost. This would likely disrupt the integrity of the core and
have not only local structural effects but also major implica-
tions for the global fold.
Not all the hydrophobic residues in AS-48 are buried in the
core; a significant number are also exposed to the solvent,
resulting in hydrophobic patches. While only three of the he-
lices, 1, 2, and 4, show modest amphipathic character, the
overall structure is highly amphipathic, as illustrated in Fig. 1
(panels e and f). The distribution of the positive charges in
AS-48 is highly asymmetrical, with most of the positively
charged residues clustered in helix 4 and in the adjacent turn
region between helices 4 and 5 (26). It is believed that this
cluster of positively charged residues is responsible for the
antimicrobial activity of AS-48 (26). The combination of an
overall positive charge and an amphipathic character is opti-
mal for interacting with and disrupting the negatively charged
bacterial membrane and has been observed in a number of
membrane-active antimicrobial proteins (53).
An indication that circular proteins are not unusual in terms
of their structural features may be seen from the fact that the
FIG. 2. Hydrophobic interactions in the core of AS-48. The hydrophobic side chains in the core are shown in grey (helices 1 to 4) and pink (helix
5) and labeled with residue numbers and single-letter amino acid codes. The importance of the side chains of helix 5 is clear from the extensive
interactions with most other regions of the core. The compactness of the fold is highlighted by the fact that all of the residues shown here have
less than 20% of their side chain surfaces exposed to the solvent. View b is rotated 90° around the y axis in relation to a.
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structure of AS-48 was predicted with high precision (to a root
mean squares distance of 4.3 A˚) in a recent protein structure
prediction competition (51). In fact, AS-48 was the only circu-
lar protein included in the competition but was better pre-
dicted than all of the linear proteins. Figure 3 shows a com-
parison of the predicted structure and the one determined
experimentally by NMR spectroscopy. It is interesting that the
presence and extent of the five helical regions and their orien-
tations in relation to each other were predicted very accurately.
However, the packing of the side chains in the hydrophobic
core is harder to predict, as illustrated by the fact that the
predicted structure is significantly less compact. In particular,
this is highlighted by helix 1, which is not closely associated
with the molecular core in the predicted structure.
While all of the other circular proteins discussed so far are
more or less involved in repelling other organisms from the
producer, TrbC and T pilin have a very different role: they
promote contact between cells. The pilins are the primary
components of the bacterial conjugative system, a very efficient
means of mediating horizontal gene transfer in a highly pro-
miscuous manner (61). Kalkum et al. found that TrbC and T
pilin, the subunits of the pili encoded by the IncP (RP4) and Ti
plasmids, respectively, were proteins with their backbones cy-
clized by peptide bonds (35). Despite being very similar in
function and size (78 versus 74 amino acids), TrbC and T pilin
do not show a high degree of sequence similarity. However,
there seem to be several conserved residues across various
pilin homologues within the core region, including six abso-
lutely conserved glycine residues (21, 43).
Although the solution structures of both TrbC and T pilin
have not been resolved to date, there are some indications of
what these proteins might look like. First, both contain a high
proportion of hydrophobic amino acids (68% for TrbC and
70% for T pilin). A characteristic of IncP pili is their tendency
to aggregate in bundles (21), which suggests that the surface of
the pili is hydrophobic, and therefore it can be surmised that at
least some extended hydrophobic areas exist on the surface of
the TrbC subunits comprising the pili. On polyacrylamide gels,
the linear form of T pilin has lower mobility than the mature
circular protein, indicating that the three-dimensional struc-
tures of the two proteins most likely differ significantly (43).
Finally, secondary-structure prediction programs have identi-
fied two putative transmembrane helices in both the circular
pilins (21).
It is known that T pili are very durable and highly resistant
to various chemical treatments that are known to destroy other
FIG. 3. Comparison of the structure of AS-48 predicted in a recent blind test of protein structure prediction, CASP4 (51) (a and b) and the
one determined by NMR spectroscopy (c and d). The helical regions are labeled 1 to 5, with helix 5 comprising the additional peptide bond linking
the N and C termini. Views b and d are rotated 90° around the y axis in relation to a and c.
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pili (44, 45). Whether the circular character of T pilin confers
this exceptional stability remains to be confirmed but seems
likely.
BIOSYNTHESIS (CLOSING THE RING)
Cyclization of the protein backbone differs from other post-
translational modifications in that it is not possible to discern
from the mature protein where in the sequence it has taken
place, only that it has. The discovery of gene sequences encod-
ing precursor proteins has provided insight into this “silent”
event by allowing the identification of the amino acids involved
in the head-to-tail linkage. Yet for a majority of circular pro-
teins, relatively little is known about the mechanism that gov-
erns the joining of the termini. No apparent homology exists
between the amino acids involved in the formation of the de
novo peptide bond or the flanking residues across the different
types of circular proteins. The cyclization of MccJ25, for in-
stance, has been reported to involve a peptide bond between
two glycine residues (55), while in AS-48 the link occurs be-
tween a methionine and a tryptophan residue (47). This covers
the complete spectrum of amino acid types from the smallest,
least sterically hindered to large, bulky ones. This disparity, in
addition to the different functions and structures of the circular
proteins, makes a ubiquitous mechanism of cyclization seem
unlikely.
All circular proteins for which the gene sequence has been
determined originate from a precursor protein with an N-
terminal signal peptide, implicating both cleavage and cycliza-
tion events in the maturation process. Whereas the AS-48,
MccJ25, GasA, and T pilin precursors comprise a signal pep-
tide followed by the mature peptide domain (33, 37, 47, 55),
the TrbC precursor and the precursors of some circular pro-
teins from plants and mammals also include N-terminal pro-
regions and C-terminal domains (21, 32, 56). These extra do-
mains, often conserved across a class of circular proteins, may
play a role in organizing the residues of the mature protein in
an orientation conducive to peptide bond formation. However,
it appears that a suitable geometric arrangement is by itself not
sufficient to result in cyclization; many proteins whose termini
are situated in close proximity remain linear (49), including
acyclic analogues of circular proteins themselves (14), and it is
therefore likely that enzymatic processes also play a role. Pro-
teolytic enzymes are obvious candidates for the necessary
cleavage (and ligation) steps involved in the biosynthesis of
macrocyclic proteins, but very few with the necessary specificity
have been characterized.
The biosynthesis of AS-48, MccJ25, and the pilins (little is
known about GasA) involves auxiliary proteins, many of which
are encoded on the same plasmid as the respective structural
genes. As a result, these bacterial systems present excellent
opportunities for dissecting the various components involved
in protein cyclization. Three genes residing on the pTUC100
plasmid, mcjBCD, are necessary for expression of the MccJ25
phenotype in addition to the precursor gene mcjA (Fig. 4a)
(55). The gene products McjB and McjC, both of which are
required for the production of active protein, are thought to be
involved in the maturation of MccJ25, but their exact function
is not well understood. McjD, a putative ABC transporter
protein involved in secretion, confers immunity to MccJ25.
AS-48 production and immunity involve the coordinated ex-
pression of 10 genes, as-48ABCC1DD1EFGH, within the as-48
gene cluster on the pMB2 plasmid (Fig. 4b) (20). Of these,
as-48ABCC1DD1 were initially identified as being necessary
for the expression of the AS-48 phenotype and, except for the
precursor protein As-48A, are all predicted to contain trans-
membrane helices, localizing them to the membrane (48). As-
48B and As-48C have been implicated in the processing of
As-48A to the mature cyclic protein. The presence of mem-
brane-spanning domains in these proteins as well as the ab-
sence of linear AS-48 analogues led Martinez-Bueno et al. (48)
to postulate that cleavage of the leader sequence and cycliza-
tion may be coupled to secretion. As-48C1DD1 and the re-
cently discovered As-48EFGH proteins all play a role in AS-48
secretion and are required for the full expression of AS-48-
mediated immunity (20).
Similar to their bactericidal counterparts, the TrbC and T
pilin precursors are proteolytically processed and cyclized, al-
though rather than being secreted, the circular proteins are
assembled into pilin filaments. Most of the proteins necessary
for pilin biogenesis are encoded on the same plasmid as the
structural gene. Eleven plasmid-encoded proteins, in addition
to the precursor proteins, are essential to both TrbC and T
pilin maturation (7, 27). Interestingly, these auxiliary proteins
are predominantly involved in making up a membrane-span-
ning translocation complex that mediates both pilin assembly
and function (Fig. 5). The only protein identified that has been
implicated in the cyclization process is TraF, encoded on the
RP4 plasmid along with TrbC. In contrast, processing of the T
pilin is entirely independent of the Ti plasmid and is therefore
assumed to be mediated by chromosomally derived proteins
(21).
Maturation of TrbC from a 145-residue precursor to a 78-
residue circular protein involves three proteolytic cleavages
and a cyclization event (Fig. 5) (21). In the first instance, a
27-amino-acid peptide is removed from the C terminus of the
precursor by an as yet unidentified enzyme. The subsequent
removal of a 36-amino-acid N-terminal signal peptide is per-
formed by LepB, a chromosomally encoded signal peptidase I,
to generate a protein that corresponds to linear TrbC with a
C-terminal tetrapeptide. The ultimate cleavage and cyclization
are attributed to TraF, a plasmid-encoded protein homologous
to the leader peptidases. Mutation studies of TraF at residues
corresponding to those conserved in leader peptidases sug-
gested that, like these serine proteases, TraF functions via a
Ser-Lys catalytic dyad (22).
A putative cyclization mechanism has been proposed in
which the final cleavage and peptide bond formation occur as
a single concerted event via an acyl intermediate catalyzed by
TraF, transferring the energy released from the cleavage reac-
tion directly to the formation of a peptide bond. The absence
of linear TrbC molecules and the presence of the tetrapeptide
in cyclization-deficient mutants support this contention, but
the involvement of an extraneous enzyme or alternative mech-
anism cannot be discounted. It is interesting that no linear
analogues identical in sequence to any naturally occurring cir-
cular proteins have been isolated. Both TrbC and TraF span
the cytoplasmic membrane during the course of their interac-
tion, most probably to optimize contact between the relevant
residues. In other circular proteins, disulfide bonds and a tight
4016 MINIREVIEWS J. BACTERIOL.
 o
n
 O
ctober 14, 2015 by University of Queensland Library
http://jb.asm.org/
D
ow
nloaded from
 
globular structure may supplant the need for membrane inter-
action.
VirB, the T pilin precursor, consists of a 47-residue N-ter-
minal signal peptide followed by the sequence of the mature
pilin protein (74 residues) (33). As in the TrbC system, pro-
teolytic cleavage of the signal peptide is also carried out by a
chromosomally encoded peptidase similar to LepB. However
no TraF homolog is present on the Ti plasmid. Interestingly,
cyclization of T pilin was found to occur in Agrobacterium
tumefaciens but not in E. coli, indicating that the enzyme or
mechanism responsible for cyclization is of chromosomal ori-
gin and species specific (43).
The diversity of both bacterial and nonbacterial precursor
sequences suggests that a single mechanism of cyclization is
unlikely to be common to all circular proteins. However, cer-
tain parallels exist between the biosynthetic pathways of dif-
ferent circular bacterial proteins. The similarity of precursor
organization, the opportunity for coupled cleavage and cycliza-
tion events, and the common accessory components, such as
membrane transporters, often coexpressed with the respective
proteins may point towards a common approach to cyclization,
albeit one which has become species specialized over evolu-
tionary time. Alternatively, the substantial benefits to protein
stability associated with forming that final peptide bond may
have been realized independently numerous times and culmi-
nated in the existence of multiple mechanisms to achieve the
same end.
The biosynthesis of circular proteins from plant and animal
cells is not as well understood as it is in bacterial systems and
is complicated by the lack of an efficient expression system. It
will be interesting to follow developments in the characteriza-
tion of components involved in the cyclization of bacterial
proteins and to access the potential for any “cross-reactivity”
between the novel processing proteins of circular proteins from
different sources.
OTHER NATURALLY OCCURRING
CIRCULAR PROTEINS
The currently known circular proteins from higher organ-
isms all contain one or more disulfide bonds, which contrasts
FIG. 4. Biosynthesis of the cyclic bacterial proteins MccJ25 and AS-48. (a) Four genes located within the mcj cluster, mcjABCD, are necessary
for the production of and immunity to MccJ25. Maturation from the precursor McjA to MccJ25 requires both McjB and McjC (blue) and, due
to the predicted absence of membrane-spanning domains in these proteins, probably occurs in the cytosol. McjD (aqua), which confers immunity
to MccJ25, shows homology to bacterial ABC exporters and has been implicated in secretion of MccJ25 from the cell. A chromosomally encoded
outer membrane protein, TolC (yellow), has since also been found to play a role in MccJ25 secretion (18). (b) Ten genes implicated in AS-48
production and immunity are located within the as-48 gene cluster, as-48ABCC1DD1EFGH, on the pMB2 plasmid. The gene products As-
48ABCC1DD1 are necessary for AS-48 production and immunity and, except for the precursor protein As-48A, are all predicted to be located in
the membrane. As-48B and As-48C (blue) are predominantly involved in AS-48 production. Their putative locations in the membrane may indicate
that AS-48 processing and cyclization are coupled to secretion, as shown here. Alone, As-48D1 (red) is able to confer immunity on the cyclic
protein AS-48, but As-48C1 and As-48D (yellow), the latter showing homology to ABC transporter proteins, enhance this resistance, and thus all
three proteins have been implicated in AS-48 secretion. The as-49EFGH operon encodes another putative ABC transporter (aqua) which was
recently shown to be required for full expression of AS-48 immunity. The precursor proteins are represented by purple strands, with the cyclic
protein domains colored orange. IM, inner membrane; OM, outer membrane.
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with the absence of such bonds in bacterial circular proteins.
They range in size from 14 to approximately 30 amino acids, as
indicated in Fig. 6. The largest family of circular proteins in
higher organisms is the plant cyclotides (11). They are typically
about 30 amino acids in size, contain an N- to C-cyclized
backbone, and incorporate three disulfide bonds arranged in a
cystine knot topology (12). In this motif, an embedded ring in
the structure formed by two disulfide bonds and their connect-
ing backbone segments is penetrated by the third disulfide
bond. The combination of this knotted and strongly braced
structure with a circular backbone renders the cyclotides im-
pervious to enzymatic breakdown and makes them exception-
ally stable. The cyclotides have a diverse range of biological
activities, ranging from uterotonic action to anti-human immu-
nodeficiency virus and neurotensin antagonism (13).
Recently, another group of Cys-rich macrocyclic peptides,
MCoTI-I and MCoTI-II, from a plant in the Cucurbitaceae
family (29) were discovered. Unlike the previously reported
cyclotides, these molecules have trypsin-inhibitory activity. The
three-dimensional structure of MCoTI-II has recently been
determined and contains a cyclic cystine knot motif (23, 28),
suggesting that these Cucurbitaceae peptides are related to the
cyclotide family. SFTI-1 is a much smaller cyclic peptide from
plants that also has trypsin-inhibitory activity. It contains just a
single disulfide bond, as illustrated in Fig. 6.
The only circular peptide so far directly discovered in ani-
mals is RTD-1 (56) and its homologues RTD-2 and RTD-3,
found in rhesus monkey leucocytes. Very recently it was re-
ported that human bone marrow also expresses a pseudogene
that apparently encodes an antimicrobial peptide, retrocyclin,
similar in sequence to RTD-1 (10). These molecules are like
the cyclotides in that they have a circular backbone and three
disulfide bonds, but differ in being about half the size of the
cyclotides and having a laddered rather than a knotted ar-
rangement of the disulfide bonds. A schematic illustration of
the structures of representative circular proteins from higher
organisms is shown in Fig. 6. As noted earlier, relatively little
is known about biosynthesis of the disulfide-containing cyclic
peptides from higher organisms, but the potential complexity is
illustrated by the fact that the 18-amino-acid peptide RTD-1 is
the product of two genes and two head-to-tail ligation reac-
tions of the encoded 9-amino-acid peptides (56).
ROLE OF THE CIRCULAR BACKBONE
One obvious question that is raised by the discovery of
macrocyclic peptides in various organisms is what the advan-
tages are of such a modification. Intuitively, the answer in-
volves improving the stability of peptides by removing possible
sites for exoproteases and constraining the conformation of the
termini, leading to an entropic advantage in binding interac-
tions. Recent studies on the influences of linearization on
naturally occurring circular proteins have suggested both a
structural and functional role for the cyclic backbone.
Cleaving AS-48 with cyanogen bromide results in a linear
form that is unable to maintain the native structure (8). Based
on this result, it appears that the cyclic backbone is required to
maintain the three-dimensional structure of AS-48. However,
as discussed earlier, AS-48 was opened by hydrolyzing the
Tyr70-Met1 bond, which is in the middle of -helix 5. Cleaving
in a different region, such as a loop, may result in retention of
the overall structure. Further analogues are required before
this can be properly assessed. However, the results do suggest
that -helix 5 itself is crucial for maintaining the structure and
that cyclization appears to have a significant structural role, as
it occurs specifically in an element of secondary structure and
not in a loop region.
Studies on the effects of breaking the backbone of nonbac-
terial circular proteins have suggested that the cyclic backbone
is not essential for maintaining the overall fold in these cases.
Synthetic linear derivatives of RTD-1 (56, 59), SFTI-1 (42),
FIG. 5. Biosynthesis of cyclic bacterial protein TrbC pilin. The TrbC
precursor is processed at both termini prior to insertion of the protein into
the inner membrane, where cyclization takes place. An unidentified pep-
tidase is responsible for proteolytic cleavage at the C terminus (pink),
while the chromosomally encoded peptidase LepB removes an N-termi-
nal peptide (purple). The membrane-spanning TraF protein (aqua), en-
coded on the RP4 plasmid with the precursor, is thought to catalyze
cyclization of TrbC in a concerted event that involves simultaneous re-
moval of a C-terminal tetrapeptide (light blue) (refer to text for details).
The cyclic TrbC units (orange) are then transferred to the cell surface and
assembled into pilin filaments with the aid of a translocation complex
comprised, at least in part, of components also encoded on the RP4
plasmid (yellow crosses). The balls on the proteins indicate transmem-
brane segments. IM, inner membrane; OM, outer membrane. Adapted in
part from Kalkum et al. (35).
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and the cyclotides (14, 15) all retain some elements of native
secondary structure. The additional restraints of the disulfide
bonds in the nonbacterial circular proteins are likely to play a
major role in maintaining the overall structure. Studies on the
naturally occurring macrocyclic trypsin inhibitor MCoTI-II
(29) also suggest that the circular backbone is not required to
maintain the overall fold, as linear homologues with similar
structures exist in nature (29). Furthermore, the loop that may
be regarded as the linker region that joins the termini to form
the cyclic structure is disordered in the NMR-derived struc-
tures of MCoTI-II (23, 28). This disorder suggests that the role
of cyclization in this particular case is not to rigidify the struc-
ture, as might be imagined. Preventing attack by exoproteases
has been suggested as a significant role for the circular back-
bone in this molecule (23, 28)
Analyses of structural stability have also provided informa-
tion on the role of the circular backbone. AS-48 was found to
be extremely resistant to heat- and denaturant-induced unfold-
ing (9). It was shown to denature only when the temperature
reached 102°C, and at low temperature it did not unfold even
in 8 M urea. It appears that the circular backbone is respon-
sible for this stability, as the other structural features are quite
standard for a protein of this size (9). Because of the lack of
structure in the linear form of AS-48, it was not possible to
perform a rigorous analysis of the thermodynamic contribu-
tions of the circular backbone. However, this has been possible
for an artificially generated cyclic PIN1 WW domain, which
has been shown to posses an improved thermodynamic stability
compared to the linear wild type (16). This protein, which
comprises 34 amino acids, adopts a triple-stranded -sheet
structure in which the two termini are close together (10 A˚
apart) on one face of the molecule. In this study, it was con-
cluded that the size of the linker used for cyclization must be
optimal to prevent the introduction of strain, which would
destabilize the native fold. For an optimal linker, a stabilization
of up to 1.7 kcal/mol was reported.
In addition to influences on the overall fold and stability, the
cyclic backbone also affects biological activity. Linear ana-
logues of RTD-1, SFTI-1, and the cyclotides all show de-
creased biological activities relative to the native peptides. This
indicates that the circular backbone is critical for maintaining
the native level of activity. Overall, while the role of the circu-
lar backbone is by no means fully understood, it appears to be
involved in improving stability and biological activity and in
some cases may be involved in the structural integrity.
CONCLUDING REMARKS
Although circular proteins have been discovered only over
the last decade, they are now found in a wide range of organ-
isms, and it is likely that many more will be discovered in the
next few years. Circular proteins of bacterial origin adopt well-
defined three-dimensional structures and have a high degree of
thermal stability and resistance to denaturation by chaotropes.
It is clear from examples such as AS-48 that circular proteins
behave very much like conventional proteins in terms of their
three-dimensional structures, i.e., that the sequence contains
all of the intrinsic information required for folding into a
defined three-dimensional shape. This is illustrated by the high
fidelity of protein structure prediction in the case of AS-48.
However, there remain some fascinating questions on the
structural biology of circular proteins, including how and why
the mechanism of cyclization evolved.
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